)
Edge
Extra Everything: The Story of Chipotle
Chipotle's story from a single restaurant to a nationwide chain, through crisis and turnaround, built on one of the strongest models in the industry.
IDEAYA Biosciences
IDEAYA Biosciences (IDYA) investor relations material
IDEAYA Biosciences Corporate presentation summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Corporate presentation summary5 May, 2026
Vision and strategy
Aims to be a leader in precision medicine oncology, focusing on first- and best-in-class programs using predictive biomarkers and AI-driven drug discovery.
Pipeline targets rational combinations and multiple solid tumor indications, including neoadjuvant, adjuvant, and first-line metastatic disease.
Drug discovery platform
Six internally discovered clinical-stage molecules address challenging targets like helicases, polymerases, and glycohydrolases.
Utilizes CRISPR-based target discovery, chemigenomics, and AI-driven drug design for accelerated IND delivery.
Achieves novel selectivity profiles and leverages proprietary structural data for computational drug discovery.
Clinical pipeline highlights
Darovasertib targets uveal melanoma (UM) with a unique PKC inhibition mechanism, showing significant efficacy in both primary and metastatic UM.
IDE849 (DLL3 ADC) and IDE161 (PARG inhibitor) show synergy in preclinical models, with IDE849 demonstrating robust responses in SCLC.
IDE034 (B7H3/PTK7 bispecific ADC) and IDE397 (MAT2A inhibitor) expand the pipeline into additional solid tumor indications.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from IDEAYA Biosciences
- Darovasertib met key endpoints in mUM, driving NDA plans and pipeline progress with $973M cash.IDYA
Q1 20265 May 2026 - Virtual meeting to elect directors, ratify auditor, and approve executive pay, all board-backed.IDYAProxy filing1 May 2026
- Proxy covers director elections, auditor ratification, and executive pay, all with board support.IDYAProxy filing29 Apr 2026
- Darovasertib plus crizotinib doubled PFS and improved ORR in HLA-A2-negative metastatic uveal melanoma.IDYAStudy result16 Apr 2026
- Phase III darovasertib readout in uveal melanoma due soon; robust pipeline and filings ahead.IDYAStatus update13 Apr 2026
- Darovasertib nears pivotal data as part of a broad, innovative oncology pipeline targeting major unmet needs.IDYA44th Annual J.P. Morgan Healthcare Conference12 Apr 2026
- Precision oncology pipeline advances with strong clinical data and $1.05B cash runway.IDYACorporate presentation23 Mar 2026
- Major data readout for darovasertib/crizotinib in uveal melanoma expected by end of March.IDYACiti’s 2026 Virtual Oncology Leadership Summit18 Feb 2026
- Strong clinical progress and improved financials, with topline trial results due March 2026.IDYAQ4 202517 Feb 2026
Next IDEAYA Biosciences earnings date
Bank of America Global Healthcare Conference 202613 May, 2026
IDEAYA Biosciences
Next IDEAYA Biosciences earnings date
Bank of America Global Healthcare Conference 202613 May, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
Related articles
)
)
Frequently asked questions
Explore our global coverage